Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Rainmed Medical Reports 41% Revenue Growth in 2026 Interim Results – caFFR Consumables Drive Gross Margin to 63.2% as Losses Narrow 31%
Company

Rainmed Medical Reports 41% Revenue Growth in 2026 Interim Results – caFFR Consumables Drive Gross Margin to 63.2% as Losses Narrow 31%

Rainmed Medical Limited (HKG: 2297), a China‑based cardiovascular precision‑diagnosis company, released its unaudited interim results for the six months ended 30 June 2026, reporting revenue of RMB14.7 million, up approximately…

China's CDE Slates Highlightll's Ginocitinib (TLL‑018) for Priority Review – First Domestic Dual‑Target JAK1/TYK2 Inhibitor for Rheumatoid Arthritis

China’s CDE Slates Highlightll’s Ginocitinib (TLL‑018) for Priority Review – First Domestic Dual‑Target JAK1/TYK2 Inhibitor for Rheumatoid Arthritis

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Seagen’s Adcetris Combo with Keytruda Shows Promising Results in Phase II Study

CompanyDrug

Zhejiang Huahai Pharmaceutical’s HB0052 Receives US FDA IND Approval for Solid Tumors

CompanyDrug

BeiGene’s ZW25 on Track for Priority Review for Cholangiocarcinoma Treatment by CDE

CompanyDrug

CSPC Pharmaceutical Group Gets NMPA Approval for SYS6011 Biologic Drug Clinical Study

CompanyDeals

Bayer Extends Collaboration with Broad Institute to 2028 for Oncology Drug Targets and Therapies

CompanyMedical Device

Amoy Diagnostics Receives NMPA Approval for MSI Detection Kit as Companion Diagnostic for Immunotherapy

CompanyDrug

Gaush Meditech Ltd Receives NMPA Approval for Rigid Corneal Contact Lens

CompanyDrug

Wuhan Hiteck Biological Pharma Receives NMPA Approval for Aponermin in Multiple Myeloma Treatment

Show More